Clinical Research Site

Tampa, Florida 33634

2 studies enrolling now · 14 studies all time

What they study most

Agitation, Agitation in Patients With Dementia of the Alzheimer's Type, Agitation, Psychomotor, Agitation,Psychomotor, Alzheimer Disease, Cataplexy, Excessive Daytime Sleepiness, Fibromyalgia, Hidradenitis Suppurativa, Migraine, Narcolepsy, Pulmonary Aspergillosis

Studies at this site

• Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design — Recruiting now
• Open-Label Safety Study of AXS-14 in Subjects With Fibromyalgia — Enrolling by invitation
• An Open-Label Study to Assess the Long-term Safety of AXS-05 in Subjects With Dementia of the Alzheimer's Type, ADVANCE-2 and ACCORD-2 Extension Study — Stopped early
• A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With Narcolepsy — Completed
• An Open-label Safety Study of PC945 (Opelconazole) Prophylaxis or Pre-emptive Therapy Against Pulmonary Aspergillosis in Lung Transplant Recipients (OPERA-S Study) — Completed
• Initiating Early Control of Migraine Pain and Associated Symptoms — Completed
• A Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Alzheimer's Disease Agitation — Completed
• A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation — Completed
• Hidradenitis Suppurativa Study of Izokibep — Stopped early
• Hidradenitis Suppurativa Phase 2b Study of Izokibep — Completed
• Assessing Clinical Outcomes in Alzheimer's Disease Agitation — Completed
• Multimechanistic Treatment Over Time of Migraine Symptoms (MOVEMENT) — Completed
• Maximizing Outcomes in Treating Acute Migraine — Completed
• Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type — Completed